NO2914282T3 - - Google Patents

Info

Publication number
NO2914282T3
NO2914282T3 NO13811605A NO13811605A NO2914282T3 NO 2914282 T3 NO2914282 T3 NO 2914282T3 NO 13811605 A NO13811605 A NO 13811605A NO 13811605 A NO13811605 A NO 13811605A NO 2914282 T3 NO2914282 T3 NO 2914282T3
Authority
NO
Norway
Application number
NO13811605A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2914282T3 publication Critical patent/NO2914282T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO13811605A 2012-10-31 2013-10-31 NO2914282T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201219602A GB201219602D0 (en) 2012-10-31 2012-10-31 Recombinant clostridium botulinum neurotoxins
PCT/GB2013/052845 WO2014068317A1 (en) 2012-10-31 2013-10-31 Recombinant clostridium botulinum neurotoxins

Publications (1)

Publication Number Publication Date
NO2914282T3 true NO2914282T3 (de) 2018-05-19

Family

ID=47358958

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13811605A NO2914282T3 (de) 2012-10-31 2013-10-31

Country Status (27)

Country Link
US (1) US10030238B2 (de)
EP (3) EP2914282B1 (de)
JP (2) JP2019068823A (de)
KR (2) KR102188539B1 (de)
CN (2) CN104755098A (de)
AR (2) AR093309A1 (de)
AU (3) AU2013340610B2 (de)
BR (1) BR112015005384A2 (de)
CA (1) CA2885519A1 (de)
DK (2) DK2914282T3 (de)
EA (1) EA201590794A8 (de)
ES (2) ES2662402T3 (de)
GB (1) GB201219602D0 (de)
HK (1) HK1208359A1 (de)
HU (2) HUE048802T2 (de)
IL (1) IL237623B (de)
IN (1) IN2015MN00436A (de)
MX (2) MX367080B (de)
NO (1) NO2914282T3 (de)
NZ (1) NZ705575A (de)
PL (2) PL3326644T3 (de)
PT (2) PT3326644T (de)
SG (2) SG11201502372SA (de)
TW (3) TWI626307B (de)
UA (1) UA118837C2 (de)
WO (1) WO2014068317A1 (de)
ZA (1) ZA201501449B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201219602D0 (en) * 2012-10-31 2012-12-12 Syntaxin Ltd Recombinant clostridium botulinum neurotoxins
CN115925835A (zh) * 2015-03-26 2023-04-07 哈佛大学校长及研究员协会 工程改造的肉毒杆菌神经毒素
WO2017063743A1 (en) 2015-10-14 2017-04-20 Merz Pharma Gmbh & Co. Kgaa Improvements to ultrasound-based therapy of photoaged tissue
MX2018008855A (es) 2016-03-02 2018-11-29 Merz Pharma Gmbh & Co Kgaa Composicion que comprende toxina botulinica.
EP3263710A1 (de) * 2016-07-01 2018-01-03 Ipsen Biopharm Limited Herstellung von aktivierten clostridien-neurotoxinen
WO2018039506A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Engineered botulinum neurotoxin
CN109803672A (zh) 2016-09-13 2019-05-24 阿勒根公司 稳定的非蛋白质梭菌毒素组合物
EP3642222A1 (de) 2017-06-20 2020-04-29 Merz Pharma GmbH & Co. KGaA Neuartiges rekombinantes botulinumtoxin mit erhöhter wirkdauer
EP3649143B1 (de) 2017-07-06 2022-08-31 Merz Pharma GmbH & Co. KGaA Novel recombinant botulinum neurotoxins with increased duration of effect
MX2020007596A (es) * 2018-01-29 2020-09-03 Ipsen Biopharm Ltd Neurotoxinas botulinicas para escindir una proteina de receptor de union a factor sensible a n-etilmaleimida soluble (snare) no neuronal.
EP3752128A1 (de) * 2018-02-16 2020-12-23 Bontana Therapies Gmbh Nukleinsäure-basiertes botulinum neurotoxin zur therapeutischen anwendung
GB201815844D0 (en) 2018-09-28 2018-11-14 Ipsen Biopharm Ltd Therapeutic & comestic uses of botulinum neurotoxin serotype e
GB202011055D0 (en) 2020-07-17 2020-09-02 Ipsen Bioinnovation Ltd Treatment of post-operative pain
GB202015618D0 (en) 2020-10-01 2020-11-18 Ipsen Biopharm Ltd Method for producing beta-trypsin
CN115819526A (zh) * 2022-12-02 2023-03-21 海雅美生物技术(珠海)有限公司 一种重组肉毒杆菌神经毒素及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6967088B1 (en) * 1995-03-16 2005-11-22 Allergan, Inc. Soluble recombinant botulinum toxin proteins
NZ308772A (en) * 1995-05-17 1999-04-29 Du Pont Recombinant baculovirus insecticides
US6495143B2 (en) 1998-07-10 2002-12-17 The United States Of America As Represented By The Secretary Of The Army Botulinum neurotoxin vaccine
WO2001014570A1 (en) * 1999-08-25 2001-03-01 Allergan Sales, Inc. Activatable recombinant neurotoxins
US7374896B2 (en) 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
WO2006011966A1 (en) * 2004-06-30 2006-02-02 Allergan, Inc. Optimizing expression of active botulinum toxin type e
US20110111483A1 (en) 2004-06-30 2011-05-12 Allergan, Inc. Optimizing Expression of Active Botulinum Toxin Type E
US7514088B2 (en) * 2005-03-15 2009-04-07 Allergan, Inc. Multivalent Clostridial toxin derivatives and methods of their use
GB2416122A (en) * 2004-07-12 2006-01-18 Ipsen Ltd Botulinum neurotoxin composition
DE102004043009A1 (de) * 2004-09-06 2006-03-23 Toxogen Gmbh Transportprotein zum Einbringen chemischer Verbindungen in Nervenzellen
DE102005002978B4 (de) 2005-01-21 2013-04-25 Merz Pharma Gmbh & Co. Kgaa Rekombinante Expression von Proteinen in einer disulfidverbrückten, zweikettigen Form
ES2509872T3 (es) * 2005-03-03 2014-10-20 Allergan, Inc. Procedimientos para obtener una toxina clostrídica
DK1926744T4 (en) * 2005-09-19 2019-01-28 Allergan Inc CLOSTRIDIUM TOXIN-ACTIVABLE CLOSTRIDIAL TOXINES
US20070218084A1 (en) * 2005-12-30 2007-09-20 Fondazione Pierfranco E Luisa Mariani- Onlus Method for the Mapping of the Epileptogenic Focus in the Pre-Surgical Evaluation of Patients with Intractable Epilepsy
EP2038299A2 (de) * 2006-07-11 2009-03-25 Allergan, Inc. Modifizierte clostridientoxine mit verbesserten translokationsfähigkeiten und geänderter targeting-aktivität für nichtclostridientoxin-targetzellen
EP2178905B1 (de) 2007-07-26 2013-11-06 Allergan, Inc. Methoden zur aktivierung von clostridientoxinen
CN105833254A (zh) 2008-12-10 2016-08-10 阿勒根公司 梭菌毒素药物组合物
GB0903006D0 (en) * 2009-02-23 2009-04-08 Syntaxin Ltd Modified non-cytotoxic proteases
CA2758274C (en) * 2009-04-14 2018-04-10 Mcw Research Foundation, Inc. Engineered botulinum neurotoxin
AU2010353292A1 (en) * 2009-12-16 2012-07-12 Allergan, Inc. Modified Clostridial toxins comprising an integrated protease cleavage site-binding domain
US20120207743A1 (en) 2011-02-14 2012-08-16 Allergan, Inc. Inhibiting Aberrant Blood Vessel Formation Using Retargeted Endopeptidases
GB201219602D0 (en) * 2012-10-31 2012-12-12 Syntaxin Ltd Recombinant clostridium botulinum neurotoxins
GB201407525D0 (en) * 2014-04-29 2014-06-11 Syntaxin Ltd Manufacture of recombinant clostridium botulinum neurotoxins
WO2018039506A1 (en) * 2016-08-24 2018-03-01 President And Fellows Of Harvard College Engineered botulinum neurotoxin

Also Published As

Publication number Publication date
TW201825680A (zh) 2018-07-16
HUE036764T2 (hu) 2018-07-30
EP3673914A1 (de) 2020-07-01
DK3326644T3 (da) 2020-05-11
SG10201701140WA (en) 2017-04-27
EA201590794A1 (ru) 2015-08-31
EP2914282B1 (de) 2017-12-20
MX2019009222A (es) 2019-11-21
PT2914282T (pt) 2018-03-13
US10030238B2 (en) 2018-07-24
AU2018203556A1 (en) 2018-06-07
SG11201502372SA (en) 2015-05-28
EP3326644A1 (de) 2018-05-30
KR20200110470A (ko) 2020-09-23
CA2885519A1 (en) 2014-05-08
NZ705575A (en) 2019-08-30
BR112015005384A2 (pt) 2017-08-08
UA118837C2 (uk) 2019-03-25
ES2788199T3 (es) 2020-10-20
IL237623B (en) 2019-05-30
AR117738A2 (es) 2021-08-25
JP2019068823A (ja) 2019-05-09
ZA201501449B (en) 2016-08-31
JP2020078321A (ja) 2020-05-28
TWI626307B (zh) 2018-06-11
EP3326644B1 (de) 2020-03-04
ES2662402T3 (es) 2018-04-06
MX2015005156A (es) 2015-09-23
KR102264478B1 (ko) 2021-06-15
TW201435084A (zh) 2014-09-16
KR20150094590A (ko) 2015-08-19
EA201590794A8 (ru) 2016-01-29
CN110499321A (zh) 2019-11-26
HK1208359A1 (en) 2016-03-04
US20150247139A1 (en) 2015-09-03
KR102188539B1 (ko) 2020-12-09
AU2013340610A1 (en) 2015-03-19
HUE048802T2 (hu) 2020-08-28
GB201219602D0 (en) 2012-12-12
TWI673361B (zh) 2019-10-01
EP3673914B1 (de) 2021-10-27
PL3326644T3 (pl) 2020-08-24
AR093309A1 (es) 2015-05-27
PT3326644T (pt) 2020-05-29
AU2013340610B2 (en) 2018-02-22
PL2914282T3 (pl) 2018-07-31
IN2015MN00436A (de) 2015-09-04
AU2020244481A1 (en) 2020-10-29
DK2914282T3 (en) 2018-02-26
WO2014068317A1 (en) 2014-05-08
CN104755098A (zh) 2015-07-01
AU2018203556B2 (en) 2020-08-20
MX367080B (es) 2019-08-05
EP2914282A1 (de) 2015-09-09
TW202012622A (zh) 2020-04-01
IL237623A0 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
BR112014017635A2 (de)
BR112014017614A2 (de)
BR112014017708A2 (de)
BR112014017625A2 (de)
BR112014021401A2 (de)
BR112014017659A2 (de)
BR112014019235A2 (de)
AR092201A1 (de)
BR112014019610A2 (de)
BR112014017607A2 (de)
BR112014017634A2 (de)
BR112014017609A2 (de)
NO2914282T3 (de)
BR112014017588A2 (de)
BR112014025069A2 (de)
BR112014024269A2 (de)
BR112014017630A2 (de)
BR112014017652A2 (de)
BR112014017621A2 (de)
BR112014017622A2 (de)
BR112014017627A2 (de)
BR112014017623A2 (de)
BR112014017631A2 (de)
BR112014017636A2 (de)
BR112014017667A2 (de)